Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease.
about
Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptorsProspective, randomized, and active controlled study of the efficacy of alginic acid and antacid in the treatment of patients with endoscopy-negative reflux disease.Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile.Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease.Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.Pathogenesis of gastro-oesophageal reflux disease and novel options for its therapy.Current pharmacological management of gastroesophageal reflux disease.The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trialsThe selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease.Neuro-regulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease.Effect of non-selective gamma-aminobutyric acid receptor stimulation on motor function of the lower oesophageal sphincter and gastro-oesophageal reflux in healthy human subjects.Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study.Baclofen systemic toxicity: Experimental histopathological and biochemical study.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms.The Medical Management of Gastro-Oesophageal Reflux Disease.The Role of Baclofen in the Treatment of Gastroesophageal Reflux Disease.
P2860
Q24650641-FA0D081C-CE17-44F6-86C7-C9A9D680CC0DQ33788450-65FEB0D8-6ACF-4FC2-B295-392070E60D9CQ34954104-FE0B26CA-3399-465B-95A8-C23A15C3D5CAQ35049112-80CEC0DC-B414-430A-BDB1-BFE77D686D9CQ35595527-D12A1409-9C1D-4493-B384-CE0F5854DF46Q36011773-1A3E43B3-9F25-442D-B67A-F020EE287E70Q37134557-DAFBF5E3-2874-4EAE-82AF-751BFD881140Q38123482-06CAA467-5A77-4624-87A9-F8D4396B4A33Q38267393-A885DA0A-006B-4393-B9DF-ED9090833F34Q38880408-BA19D9C6-456C-49B1-9CE0-07FC57B3E12BQ43066275-3B7E510A-8CAD-405F-8F6D-136FB6090ACDQ44596959-03BCC293-F81C-4549-A76D-3B3BA252883DQ45985042-73145195-220A-4D2D-8956-1150DEACBF6AQ46676457-F37C999A-EB6A-46DB-AC8F-F152A74A648DQ46737082-A22351CF-6657-4484-B301-501B58A9F998Q50129556-1D77871A-CCE5-4457-8DF3-10DCB48981D1Q53293551-74CF965D-6433-450F-9FB8-FDD838323B46Q55233746-1D3FF1BF-3E29-43B6-9F9B-6C44D66862C2Q55375116-9BDFFDDC-5598-42BE-8341-931D076E1593
P2860
Baclofen-mediated gastro-oesophageal acid reflux control in patients with established reflux disease.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Baclofen-mediated gastro-oesop ...... th established reflux disease.
@en
Baclofen-mediated gastro-oesop ...... th established reflux disease.
@nl
type
label
Baclofen-mediated gastro-oesop ...... th established reflux disease.
@en
Baclofen-mediated gastro-oesop ...... th established reflux disease.
@nl
prefLabel
Baclofen-mediated gastro-oesop ...... th established reflux disease.
@en
Baclofen-mediated gastro-oesop ...... th established reflux disease.
@nl
P2093
P2860
P1476
Baclofen-mediated gastro-oesop ...... th established reflux disease.
@en
P2093
Johnsson E
P2860
P304
P356
10.1046/J.1365-2036.2002.01250.X
P407
P577
2002-05-01T00:00:00Z